• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price

Mosby's Oncology Drug Reference

9780323028189
216.67 zł
195.00 zł Save 21.67 zł Tax included
Lowest price within 30 days before promotion: 195.00 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Mosbys Oncology Drug Reference is a complete, portable handbook that provides you with more data in a more accessible format than any other oncology drug reference book. In addition to current, clinically relevant drug information, special nursing considerations highlight your specific role and responsibility with respect to administration, patient monitoring, and patient education for each drug. Youll easily find the accurate, relevant, practical information you need because this handbook was written by an outstanding consulting team consisting of an oncology nurse and two pharmaceutical experts!
Product Details
Mosby
34184
9780323028189
9780323028189

Data sheet

Publication date
2007
Issue number
1
Cover
paperback
Pages count
576
Dimensions (mm)
127 x 210
Weight (g)
617
  • Unit 1. Drugs for Cancer (alphabetical listing by generic name)

    Unit 2. Pediatric Oncology

    Unit 3. Supportive Care


    1. Management of Hematologic Toxicities of Chemotherapy

    2. Chemotherapy-induced Nausea and Vomiting

    3. Mucositis Treatment and Prevention

    4. Constipation and Diarrhea

    5. Bone disorders

    6. Cancer Pain

    Unit 4. Drug Interactions

    Unit 5. Considerations for Preventing Medication Errors

    Unit 6. Occupational Exposure to Hazardous Drugs

    Appendices


    -Useful formulas

    -Chemotherapy Regimens and Drug Information on the Web

    -Patient Assistance Programs

    -Newly Approved Drugs
Comments (0)